Suptavumab

Modify Date: 2024-04-03 12:02:26

Suptavumab structure	Common Name	Suptavumab
	CAS Number	1629615-23-1	Molecular Weight	N/A
	Density	N/A	Boiling Point	N/A
	Molecular Formula	N/A	Melting Point	N/A
	MSDS	N/A	Flash Point	N/A

Use of Suptavumab

Suptavumab (REGN2222) is a human monoclonal antibody. Suptavumab can bind and block a conserved epitope on RSV A and B subtypes. Suptavumab can be used for the research of RSV infection[1][2].

Name	Suptavumab

Description	Suptavumab (REGN2222) is a human monoclonal antibody. Suptavumab can bind and block a conserved epitope on RSV A and B subtypes. Suptavumab can be used for the research of RSV infection[1][2].
Related Catalog	Research Areas >> Infection Signaling Pathways >> Anti-infection >> RSV
In Vitro	Suptavumab 抑制 RSV 与细胞融合[2]。
References	[1]. Simões EAF, et al. Suptavumab for the Prevention of Medically Attended Respiratory Syncytial Virus Infection in Preterm Infants. Clin Infect Dis. 2021 Dec 6;73(11):e4400-e4408. [2]. Rodriguez-Fernandez R, et al. Monoclonal Antibodies for Prevention of Respiratory Syncytial Virus Infection. Pediatr Infect Dis J. 2021 May 1;40(5S):S35-S39.

No Any Chemical & Physical Properties

Suptavumab

Use of Suptavumab

Names

Suptavumab Biological Activity

Chemical & Physical Properties